Advice
in the absence of a submission from the holder of the marketing authorisation
botulinum toxin type A (Botox®) is not recommended for use within NHS Scotland.
Indication under review: focal lower limb spasticity, including the treatment of ankle disability due to lower limb spasticity associated with stroke in adults.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice110KB (PDF)
Medicine details
- Medicine name:
- botulinum toxin type A (Botox)
- SMC ID:
- 986/14
- Indication:
- Focal lower limb spasticity, including the treatment of ankle disability due to lower limb spasticity associated with stroke in adults.
- Pharmaceutical company
- Allergan Ltd
- BNF chapter
- Central nervous system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 July 2014